DAPTOMYCIN FOR INJECTION DIN 02460017
Health Canada record
| Active ingredient(s) | DAPTOMYCIN 500 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01XX09 DAPTOMYCIN |
| Original market date | |
| Current status date | 16-Oct-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DAPTOMYCIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02465493 | CUBICIN RF | CUBIST PHARMACEUTICALS LLC | Powder For Solution | DAPTOMYCIN 500 MG | Marketed |
| 02490838 | DAPTOMYCIN FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | DAPTOMYCIN 500 MG | Marketed |
| 02490463 | DAPTOMYCIN FOR INJECTION | DR REDDY'S LABORATORIES LTD | Powder For Solution | DAPTOMYCIN 500 MG | Marketed |
| 02541920 | DAPTOMYCIN FOR INJECTION RF | EUGIA PHARMA INC. | Powder For Solution | DAPTOMYCIN 500 MG | Approved |
| 02540266 | DAPTOMYCIN FOR INJECTION RF | AURO PHARMA INC | Powder For Solution | DAPTOMYCIN 500 MG | Approved |
| 02299909 | CUBICIN | CUBIST PHARMACEUTICALS LLC | Powder For Solution | DAPTOMYCIN 500 MG | Dormant |
| 02494590 | DAPTOMYCIN FOR INJECTION | ACCORD HEALTHCARE INC | Powder For Solution | DAPTOMYCIN 500 MG | Cancelled Post Market |
| 02511738 | DAPTOMYCIN FOR INJECTION | JUNO PHARMACEUTICALS CORP. | Powder For Solution | DAPTOMYCIN 500 MG | Cancelled Pre Market |
| 02526743 | DAPTOMYCIN FOR INJECTION | DR REDDY'S LABORATORIES LTD | Powder For Solution | DAPTOMYCIN 350 MG | Cancelled Pre Market |
| 02462117 | DAPTOMYCIN FOR INJECTION | TEVA CANADA LIMITED | Powder For Solution | DAPTOMYCIN 500 MG | Cancelled Pre Market |
| 02460009 | DAPTOMYCIN FOR INJECTION | PFIZER CANADA ULC | Powder For Solution | DAPTOMYCIN 350 MG | Cancelled Pre Market |
| 02518856 | DAPTOMYCIN FOR INJECTION RF | BAXTER CORPORATION | Powder For Solution | DAPTOMYCIN 500 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22685 | 2019-09-25 | Abbreviated New Drug Submission (ANDS) |
International API supply for DAPTOMYCIN
13 active FDA Drug Master Files.
Request a quote for DAPTOMYCIN FOR INJECTION